The inhibition of tube formation in a collagen-fibrinogen, three-dimensional gel by cleaved kininogen (HKa) and HK domain 5 (D5) is dependent on Src family kinases
- Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA 19140 (United States)
Cleaved high molecular weight kininogen (HKa), as well as its domain 5 (D5), inhibits migration and proliferation induced by angiogenic factors and induces apoptosis in vitro. To study its effect on tube formation we utilized a collagen-fibrinogen, three-dimensional gel, an in vitro model of angiogenesis. HKa, GST-D5 and D5 had a similar inhibitory effect of tube length by 90 {+-} 4.5%, 86 {+-} 5.5% and 77 {+-} 12.9%, respectively. D5-derived synthetic peptides: G440-H455 H475-H485 and G486-K502 inhibited tube length by 51 {+-} 3.7%, 54 {+-} 3.8% and 77 {+-} 1.7%, respectively. By a comparison of its inhibitory potency and its sequences, a functional sequence of HKa was defined to G486-G496. PP2, a Src family kinase inhibitor, prevented tube formation in a dose-dependent manner (100-400 nM), but PP3 at 5 {mu}M, an inactive analogue of PP2, did not. HKa and D5 inhibited Src 416 phosphorylation by 62 {+-} 12.3% and 83 {+-} 6.1%, respectively. The C-terminal Src kinase (Csk) inhibits Src kinase activity. Using a siRNA to Csk, expression of Csk was down-regulated by 86 {+-} 7.0%, which significantly increased tube length by 27 {+-} 5.8%. The addition of HKa and D5 completely blocked this effect. We further showed that HKa inhibited Src family kinase activity by disrupting the complex of uPAR, {alpha}v{beta}3 integrin and Src. Our results indicate that the anti-angiogenic effect of HKa and D5 is mediated at least in part through Src family kinases and identify a potential novel target for therapeutic inhibition of neovascularization in cancer and inflammatory arthritis.
- OSTI ID:
- 21045939
- Journal Information:
- Experimental Cell Research, Vol. 314, Issue 4; Other Information: DOI: 10.1016/j.yexcr.2007.10.008; PII: S0014-4827(07)00476-4; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0014-4827
- Country of Publication:
- United States
- Language:
- English
Similar Records
TRAF6 inhibits proangiogenic signals in endothelial cells and regulates the expression of vascular endothelial growth factor
Angiogenic activity of sesamin through the activation of multiple signal pathways